🇺🇸 FDA
Patent

US 7247615

Peptide agonists of prostate-specific antigen and uses therefor

granted A61KA61K38/00A61P

Quick answer

US patent 7247615 (Peptide agonists of prostate-specific antigen and uses therefor) held by THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services expires Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jul 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K38/00, A61P, A61P13/08, A61P35/00